在埃塞俄比亚的前列腺癌查和相关因素:系统审查和元分析
Tadele Lankrew Ayalew1, Mulualem Gete Feleke2, Kidist Ashager2
1Department of Nursing, school of nursing, college of Health Science and Medicine, Wolaita Sodo University, P.O. Box 138, Sodo, Ethiopia. tadelelankrew@gmail.com.
BMC cancer
|January 7, 2026
概括
埃塞俄比亚的前列腺癌查率很低,为30.37%,区域差异很大. 意识,年龄较大,收入较高和家族史是影响查参与的关键因素. 针对性干预对于早期检测至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 前列腺癌对全球健康构成重大挑战,特别是在低收入和中等收入国家.
- 埃塞俄比亚面临前列腺癌查率较低的情况,这限制了早期检测工作.
- 在埃塞俄比亚,对查服务的认识和获取有限,阻碍了有效的前列腺癌控制.
研究的目的:
- 系统地审查和对埃塞俄比亚前列腺癌查的流行情况进行元分析.
- 为了确定与前列腺癌查吸收相关的因素.
- 为改善前列腺癌查率提供有针对性的干预信息.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 在多个数据库 (PubMed,Scopus,Web of Science,AJOL,Google Scholar) 中进行全面的文献搜索.
- 包括观察性研究;数据提取和使用纽卡斯尔-太华尺度进行质量评估;随机效应元分析以进行聚合流行率估计.
主要成果:
- 对12项涉及7,526名参与者的研究分析显示,前列腺癌查的综合患病率为30.37%.
- 观察到显著的区域差异,Wolaita Sodo的流行率最高 (63.08%),埃塞俄比亚中部的流行率最低 (7.19%).
- 与查积极相关的因素包括意识,45岁以上的年龄,定期的癌症检查,收入≥5000 ETB,家族病史和先前对前列腺癌的了解.
结论:
- 埃塞俄比亚的前列腺癌查率较低,区域差异很大.
- 在特定的人口结构中,查的普及率更高:老年男性,高收入人群,有先前意识的人,家庭病史或定期健康检查的人.
- 迫切需要有针对性的教育计划和加强查可访问性;未来的研究应该采用纵向,混合方法设计来评估干预和影响因素.
更多相关视频
相关概念视频
01:20Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645